Adult Immunization Update
- 17 September 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 322 (11), 1096-1097
- https://doi.org/10.1001/jama.2019.12739
Abstract
Immunization guidelines for adults are routinely updated, and primary care clinicians should be aware of the most current immunization recommendations. Within the past 2 years, 2 new vaccines were approved by the US Food and Drug Administration (FDA) for adults. These include Shingrix, a herpes zoster vaccine containing a specific protein subunit of the virus (recombinant glycoprotein E) with a novel adjuvant (an added substance that enhances or prolongs the immunologic response), and Heplisav-B, a single-antigen recombinant hepatitis B vaccine with a novel adjuvant. The eTable in the Supplement details the Advisory Committee on Immunization Practices (ACIP) 2019 immunization schedule for adults by age group.1This publication has 9 references indexed in Scilit:
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell TransplantationJAMA, 2019
- Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing HomelessnessMorbidity and Mortality Weekly Report (MMWR), 2019
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019Morbidity and Mortality Weekly Report (MMWR), 2019
- Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysisThe Journal of Infectious Diseases, 2018
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza SeasonMMWR. Recommendations and Reports, 2018
- Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel AdjuvantMorbidity and Mortality Weekly Report (MMWR), 2018
- Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster VaccinesMorbidity and Mortality Weekly Report (MMWR), 2018
- Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016Morbidity and Mortality Weekly Report (MMWR), 2017
- Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)Morbidity and Mortality Weekly Report (MMWR), 2015